Pharma Services

THOUGHT LEADERSHIP

Evolution, innovation, and disruption across healthcare is common - and the momentum within outsourced pharma services continues to fuel market attention and activity. The on-going shift to specialty medicine and precision medicine, and the macro forces advancing patient-centricity, evidence-based practices, and value-based initiatives has created the backdrop for robust interest, investment, and innovation in the pharma services landscape.

OCTOBER 2022

Get Report

The seven pharma services sub-sectors outlined in this report demonstrate this momentum and highlight the future opportunity:

Decentralized Clinical Trials (DCT)
Real-World Data, Evidence, Research, and Data Interoperability
Medical Affairs and Communication (MAC)
Market Access
Patient Services
HUB Services
Tech-Enabled Commercialization Services:

THOUGHT LEADERSHIP

SHARE

TAGS